References
- Lebbe M, Woodruff TK. Involvement of androgens in ovarian health and disease. Mol Hum Reprod 2013;19:828–37
- Walters KA. Role of androgens in normal and pathological ovarian function. Reproduction 2015;149:R193–218
- Shohat-Tal A, Sen A, Barad DH, et al. Genetics of androgen metabolism in women with infertility and hypoandrogenism. Nat Rev Endocrinol 2015;11:429–41
- Michael AE, Glenn C, Wood PJ, et al. Ovarian 11beta-Hydroxysteroid Dehydrogenase (11betaHSD) Activity is suppressed in women with an ovulatory Polycystic Ovary Syndrome (PCOS): apparent role for ovarian androgens. J Clin Endocrinol Metab 2013;98:3375–83
- Tziomalos K, Katsikis I, Papadakis E, et al. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome. Hum Reprod 2013;28:785–93
- Nardo LG, Yates AP, Roberts SA, et al. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Hum Reprod 2009;24:2917–23
- Gonzalez-Comadran M, Duran M, Sola I, et al. Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis. Reprod Biomed Online 2012;25:450–9
- Weghofer A, Kim A, Barad DH, Gleicher N. The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation. Hum Reprod 2012;27:3287–93
- Bosdou JK, Venetis CA, Kolibianakis EM, et al. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update 2012;18:127–45
- Sunkara SK, Coomarasamy A, Arlt W, Bhattacharya S. Should androgen supplementation be used for poor ovarian response in IVF? Hum Reprod 2012;27:637–40
- Davison SL, Bell R, Donath S, et al. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005;90:3847–53
- Van Voorhis BJ. Clinical practice. In vitro fertilization. N Engl J Med 2007;356:379–86
- Shrim A, Elizur SE, Seidman DS, et al. Elevated day 3 FSH/LH ratio due to low LH concentrations predicts reduced ovarian response. Reprod Biomed Online 2006;12:418–22
- Mukherjee T, Copperman AB, Lapinski R, et al. An elevated day three follicle-stimulating hormone: luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril 1996;65:588–93
- Lledo B, Llacer J, Turienzo A, et al. Androgen receptor CAG repeat length is associated with ovarian reserve but not with ovarian response. Reprod Biomed Online 2014;29:509–15
- Frattarelli JL, Gerber MD. Basal and cycle androgen levels correlate with in vitro fertilization stimulation parameters but do not predict pregnancy outcome. Fertil Steril 2006;86:51–7
- Qin YY, Zhao ZY, Sun M, Geng L, Che L, Chen ZJ. Association of basal serum testosterone levels with ovarian response and in vitro fertilization outcome. Reprod Biol Endocrinol 2011;9:9. doi: 10.1186/1477-7827-9-9
- Sun B, Wang F, Sun J, et al. Basal serum testosterone levels correlate with ovarian response but do not predict pregnancy outcome in non-PCOS women undergoing IVF. J Assist Reprod Gen 2014;31:829–35
- Gleicher N, Barad DH. Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reprod Biol Endocrinol 2011;9:67. doi: 10.1186/1477-7827-9-67
- Kim CH, Howles CM, Lee HA. The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders. Fertil Steril 2011;95:679–83
- Frattarelli JL, Peterson EH. Effect of androgen levels on in vitro fertilization cycles. Fertil Steril 2004;81:1713–14
- Lu Q, Shen H, Li Y, et al. Low testosterone levels in women with diminished ovarian reserve impair embryo implantation rate: a retrospective case-control study. J Assist Reprod Gen 2014;31:485–91
- Gleicher N, Weghofer A, Barad DH. Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS). Reprod Biol Endocrinol 2010;8:140. doi: 10.1186/1477-7827-8-140
- Gleicher N, Ryan E, Weghofer A, et al. Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study. Reprod Biol Endocrinol 2009;7:108. doi: 10.1186/1477-7827-7-108
- Cocksedge KA, Saravelos SH, Wang Q, et al. Does free androgen index predict subsequent pregnancy outcome in women with recurrent miscarriage? Hum Reprod 2008;23:797–802